March 2016

Review Article 
Minimally invasive function-preserving surgery based on sentinel node concept in early gastric cancer
Hiroya Takeuchi, Yuko Kitagawa
Translational Gastroenterology and Hepatology  
2016,  
1:
23  
Meet the Professor 
Professor Do Joong Park: deep thoughts on the development of sentinel node navigation surgery
Josie C. Huang
Translational Gastroenterology and Hepatology  
2016,  
1:
22  
Meet the Professor 
Professor Seung Ho Choi: experience in gastric cancer and type 2 diabetes
Josie C. Huang
Translational Gastroenterology and Hepatology  
2016,  
1:
21  
Case Report 
Multiple localized metachronous recurrences in a patient of colon cancer and therapeutic controversies in stage II colon cancer
Vijai Simha, Rakesh Kapoor, Saniya Sharma
Translational Gastroenterology and Hepatology  
2016,  
1:
20  
Meet the Professor 
Dr. Daniel Coit: the challenge of clinical staging of EGJ cancer
Suki X. Tang
Translational Gastroenterology and Hepatology  
2016,  
1:
19  
Letter to the Editor 
Letter in response to “Our HER2 is same as yours”
Satoshi Matsusaka, Kazuhiro Yoshida
Translational Gastroenterology and Hepatology  
2016,  
1:
18  
Letter to the Editor 
Commentary on “Perioperative hypothermia: turning up the heat on the conversation”
Rebeccah B. Baucom, Benjamin K. Poulose, Timothy M. Geiger
Translational Gastroenterology and Hepatology  
2016,  
1:
17  
Commentary 
Cancer stem cell-associated microRNAs: searching for markers and targets in hepatocellular carcinoma
Ruben Hernandez-Alcoceba, Puri Fortes
Translational Gastroenterology and Hepatology  
2016,  
1:
16  
Commentary 
Screening colonoscopy intervals in familial colorectal cancer
Matthew F. Kalady
Translational Gastroenterology and Hepatology  
2016,  
1:
15  
Commentary 
Is the transthoracic approach no longer a viable option for Siewert type II esophagogastric junction carcinoma?
Hiroharu Yamashita, Yasuyuki Seto
Translational Gastroenterology and Hepatology  
2016,  
1:
14  
Commentary 
Sorafenib in adjuvant setting: call for precise and personalized therapy
Wei Zhang
Translational Gastroenterology and Hepatology  
2016,  
1:
13  
Commentary 
Ethnicity-related differences in tumor immunity: a new possible explanation for gastric cancer prognostic variability?
Daniele Marrelli, Karol Polom, Franco Roviello
Translational Gastroenterology and Hepatology  
2016,  
1:
11  
Commentary 
A “perfect” lymph node staging system requires a “perfect” surgery
Laura Ruspi, Federica Galli, Francesco Frattini, Chiara Peverelli, Giuseppe Di Rocco, Francesco Martignoni, Francesca Rovera, Luigi Boni, Gianlorenzo Dionigi, Stefano Rausei
Translational Gastroenterology and Hepatology  
2016,  
1:
10  
Commentary 
Survival impact of the number of lymph node dissection on stage I–III node-negative gastric cancer
Jun-Te Hsu, Ta-Sen Yeh, Yi-Yin Jan
Translational Gastroenterology and Hepatology  
2016,  
1:
9  
Commentary 
Glypican-1 exosomes: do they initiate a new era for early pancreatic cancer diagnosis?
Laura Lorenzon, Giovanni Blandino
Translational Gastroenterology and Hepatology  
2016,  
1:
8  
Commentary 
Is postoperative chemoradiotherapy benefit to D2-resected gastric cancer?
Xin Wang, Jing Jin
Translational Gastroenterology and Hepatology  
2016,  
1:
7  
Case Report 
Disseminated gastric carcinoma in disguise—presentation as microangiopathic haemolytic anemia with bone marrow necrosis
Jyotsna Yesodharan, Shalini Kuruvilla, Kanjirakkad Parameswaran Kavitha, Madhavan Lilly
Translational Gastroenterology and Hepatology  
2016,  
1:
6  
Review Article 
A review on robotic surgery in rectal cancer
Zairul Azwan Mohd Azman, Seon-Hahn Kim
Translational Gastroenterology and Hepatology  
2016,  
1:
5  
Review Article 
Clinical trials to reduce pancreatic fistula after pancreatic surgery—review of randomized controlled trials
Yuji Kitahata, Manabu Kawai, Hiroki Yamaue
Translational Gastroenterology and Hepatology  
2016,  
1:
4  
Editorial 
Ataxia telangiectasia mutated (ATM), could it be another useful biomarker for the successful treatment with the poly (ADP-ribose) polymerase inhibitor?
Suk-young Lee, Sang Cheul Oh
Translational Gastroenterology and Hepatology  
2016,  
1:
3  
Editorial 
A STORM in a teacup?—the challenges of adjuvant therapy in hepatocellular carcinoma (HCC)
Kirti Shetty, Aiwu Ruth He
Translational Gastroenterology and Hepatology  
2016,  
1:
2  
Editorial 
Is a “wait-and-see” policy the best for small gastric gastrointestinal stromal tumor (GIST)?
Tatsuo Kanda
Translational Gastroenterology and Hepatology  
2016,  
1:
1